Delivery Order SPE2DB24D1007-SPE2DB25FB5RN
- Not listed
- The Defense Logistics Agency awarded a $11,097.32 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $6,132.01 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This firm fixed price, competitively awarded contract represents a non-set-aside procurement and is scheduled for completion by September 29, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $1,089.41. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement process. The order is set to reach completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $11,596.65 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-unit package). This firm fixed-price, non-set-aside contract is set for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $21,499.39 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for November 21, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $21,488.46 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $17,242.86 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This competitively awarded, firm fixed price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $64,939.14 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) at a ceiling value of $63,083.25 under a firm fixed-price arrangement. This is a competitively awarded, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,076.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FB5RNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $36,826.86 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated consistent capability in fulfilling competitively awarded Defense Logistics Agency contracts across a broad spectrum of pharmaceutical products and medical supplies. The company's extensive federal contract portfolio reflects its role as a key provider of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Trelegy Ellipta, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease, exemplifies the types of specialty pharmaceutical commodities supplied through the company's DLA prime vendor agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.8k | 9/22/25 |